AR057351A1 - Proceso para la sintesis de imidazol bencilaminas - Google Patents

Proceso para la sintesis de imidazol bencilaminas

Info

Publication number
AR057351A1
AR057351A1 ARP060102368A ARP060102368A AR057351A1 AR 057351 A1 AR057351 A1 AR 057351A1 AR P060102368 A ARP060102368 A AR P060102368A AR P060102368 A ARP060102368 A AR P060102368A AR 057351 A1 AR057351 A1 AR 057351A1
Authority
AR
Argentina
Prior art keywords
methyl
imidazol
bencilaminas
synthesis
trifluoro
Prior art date
Application number
ARP060102368A
Other languages
English (en)
Spanish (es)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR057351A1 publication Critical patent/AR057351A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ARP060102368A 2005-06-09 2006-06-07 Proceso para la sintesis de imidazol bencilaminas AR057351A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68892005P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
AR057351A1 true AR057351A1 (es) 2007-11-28

Family

ID=37085334

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102368A AR057351A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de imidazol bencilaminas

Country Status (20)

Country Link
US (1) US7709657B2 (enExample)
EP (1) EP1896425B1 (enExample)
JP (1) JP5139273B2 (enExample)
KR (1) KR101319071B1 (enExample)
CN (1) CN101193866B (enExample)
AR (1) AR057351A1 (enExample)
AT (1) ATE483690T1 (enExample)
AU (1) AU2006258116B2 (enExample)
BR (1) BRPI0611924A2 (enExample)
CA (1) CA2610402C (enExample)
DE (1) DE602006017369D1 (enExample)
ES (1) ES2354115T3 (enExample)
GT (1) GT200600207A (enExample)
MX (1) MX2007015420A (enExample)
PE (1) PE20070084A1 (enExample)
PL (1) PL1896425T3 (enExample)
PT (1) PT1896425E (enExample)
RU (1) RU2404167C2 (enExample)
TW (1) TW200710084A (enExample)
WO (1) WO2006135619A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
GB0618832D0 (en) * 2006-09-25 2006-11-01 Phoenix Chemicals Ltd Chemical process
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
CN106536303B (zh) 2014-05-16 2019-08-13 罗伯特·博世有限公司 Abs液压单元
KR102335216B1 (ko) 2017-04-26 2021-12-03 삼성전자 주식회사 발광소자 패키지
CN107235910B (zh) * 2017-07-31 2020-04-24 安礼特(上海)医药科技有限公司 一种尼洛胺的合成方法
CN108530364B (zh) 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
TWI787523B (zh) 2018-06-15 2022-12-21 漢達生技醫藥股份有限公司 達沙替尼十二烷基硫酸鹽之結晶
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
DE69429078T2 (de) * 1993-10-01 2002-07-11 Novartis Ag, Basel Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
US6323366B1 (en) * 1997-07-29 2001-11-27 Massachusetts Institute Of Technology Arylamine synthesis
US6395916B1 (en) * 1998-07-10 2002-05-28 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
PE20040522A1 (es) * 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
US7202367B2 (en) * 2002-05-31 2007-04-10 Rhodia Chimie Process for arylating or vinylating or alkynating a nucleophilic compound
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
PL1896425T3 (pl) 2011-04-29
GT200600207A (es) 2007-01-15
US20080200691A1 (en) 2008-08-21
CA2610402A1 (en) 2006-12-21
CN101193866B (zh) 2011-01-19
JP5139273B2 (ja) 2013-02-06
EP1896425B1 (en) 2010-10-06
RU2007147927A (ru) 2009-07-20
CN101193866A (zh) 2008-06-04
AU2006258116B2 (en) 2010-11-25
ES2354115T3 (es) 2011-03-10
US7709657B2 (en) 2010-05-04
WO2006135619A1 (en) 2006-12-21
MX2007015420A (es) 2008-02-21
BRPI0611924A2 (pt) 2010-10-05
PE20070084A1 (es) 2007-03-09
AU2006258116A1 (en) 2006-12-21
RU2404167C2 (ru) 2010-11-20
DE602006017369D1 (de) 2010-11-18
EP1896425A1 (en) 2008-03-12
KR101319071B1 (ko) 2013-10-17
PT1896425E (pt) 2010-11-30
CA2610402C (en) 2014-09-16
JP2008545782A (ja) 2008-12-18
KR20080016618A (ko) 2008-02-21
ATE483690T1 (de) 2010-10-15
TW200710084A (en) 2007-03-16

Similar Documents

Publication Publication Date Title
CY1116997T1 (el) Μεθοδος για παραγωγη παραγωγου 1-τριαζολο-2-βουτανολης
WO2007109810A3 (en) Methods for the preparation of imidazole-containing compounds
TN2010000052A1 (fr) Derives de pyrazole et leur utilisation comme inhibiteurs de raf
MXPA06013534A (es) Compuesto de cinamida.
TN2010000102A1 (en) Novel fungicides
MX2010001745A (es) Imidazoles fusionados para el tratamiento del cancer.
AR094588A2 (es) Proceso de obtención de un compuesto derivado de benzimidazol y composición farmacéutica
CO6251313A2 (es) Proceso para la preparacion de pirazoles
MX2010001415A (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c.
TW200716563A (en) Process for the synthesis of organic compounds
MA33361B1 (fr) Composés de triazole portant un substituant soufré
PE20110930A1 (es) 3,5-bis(3,4-dihidroxifenil)-1,2,4-triazol y la composicion que lo comprende
RU2009130066A (ru) Производные фуразана, способ их получения и содержащие их энергетические композиции
WO2009084029A3 (en) Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol
WO2020210174A4 (en) Sulfonyldiazoles and n-(fluorosulfonyl)azoles, and methods of making the same
UY31013A1 (es) Metodos para prepar compuestos basados en imidazol
BR112013021201A2 (pt) método de preparação de carfentrazona-etílica
NO20071817L (no) Fremgangsmate for a fremstille enantiomeriske imidazolforbindelser
NZ595579A (en) 5-Difluoromethoxy-4-hydroxymethyl-1-methyl-3-trifluoromethyl-pyrazole / (5-(difluoromethoxy)-3-(trifluoromethyl)-1-methyl-1H-pyrazol-4-yl)methanol
IL185545A0 (en) Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors
WO2009069312A1 (ja) (1h-1,2,4-トリアゾール-1-イル)アリール化合物及びその製造方法
WO2008075163A3 (en) An improved process for the preparation of rizatriptan
WO2007013096A8 (en) Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole)
PE20070084A1 (es) Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-bencenamina
BRPI0509731A (pt) pirazol[4,3-d]pirimidinas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal